US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nuvectis Pharma, Inc.

8.89

+0.48005.71%

Post-market: 8.890.00000.00%16:55 EST

Volume:82.76K

Turnover:731.20K

Market Cap:227.72M

PE:-6.54

High:8.97

Open:8.57

Low:8.35

Close:8.41

52wk High:11.52

52wk Low:5.55

Shares:25.61M

Float Shares:14.54M

Volume Ratio:1.11

T/O Rate:0.57%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.3595

EPS(LYR):-1.1103

ROE:-145.00%

ROA:-62.40%

PB:9.48

PE(LYR):-8.01

Loading ...

Overview Company News Filings

Nuvectis Pharma Announces the Initiation of the Phase 1B Study of Nxp900 in Combination With Osimertinib in Patients With Nsclc

THOMSON REUTERS

Nuvectis Pharma Announces the Initiation of the Phase 1b Study of NXP900 in Combination with Osimertinib in Patients with NSCLC

Nuvectis Pharma Hosts Virtual Meeting on NXP900 Phase 1b Program in Advanced Solid Tumors

Buy Rating for Nuvectis Pharma’s NXP900 Driven by Promising Efficacy and Development Progress

Nuvectis Pharma Executives Make Bold Moves with Major Stock Purchases!

Director Matthew L. Kaplan Acquires Common Shares of Nuvectis Pharma Inc

Maxim Group Reaffirms Their Buy Rating on Nuvectis Pharma (NVCT)

Nuvectis Pharma Reports Progress in Oncology Drug Development

Analysts Offer Insights on Healthcare Companies: Alpha Teknova (TKNO) and Nuvectis Pharma (NVCT)

Nuvectis Pharma Q3 EPS $(0.44) Misses $(0.25) Estimate

BRIEF-Nuvectis Pharma Q3 EPS USD -0.44

Nuvectis Pharma Q3 net loss widens

Nuvectis Pharma Inc: Cash Runway Expected to Support Company's Operations Into 3Q-2027

THOMSON REUTERS

Nuvectis Pharma reports third quarter net loss of $7.5 million

Nuvectis Pharma Q3 Net Income USD -7.5 Million

THOMSON REUTERS

Nuvectis Pharma, Inc. Reports Third Quarter 2025 Financial Results and Business Highlights

Nuvectis Pharma Inc. Files Initial Statement of Beneficial Ownership; Director Juan Sanchez Named as Beneficial Owner

Major Investment Alert: Insider Buys Big in Nuvectis Pharma!

Roth MKM Sticks to Its Buy Rating for Nuvectis Pharma (NVCT)

Nuvectis Pharma’s Phase 1 Study of NXP900: A Potential Game-Changer in Cancer Treatment

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NVCT/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"NVCT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVCT\",,,,,undefined,":{"symbol":"NVCT","market":"US","secType":"STK","nameCN":"Nuvectis Pharma, Inc.","latestPrice":8.89,"timestamp":1770411600000,"preClose":8.41,"halted":0,"volume":82764,"hourTrading":{"tag":"盘后","latestPrice":8.89,"preClose":8.89,"latestTime":"16:55 EST","volume":3100,"amount":27558,"timestamp":1770414923862,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.05707491082045189,"floatShares":14536600,"shares":25614896,"eps":-1.359454,"marketStatus":"Market Closed","change":0.48,"latestTime":"02-06 16:00:00 EST","open":8.57,"high":8.965,"low":8.3452,"amount":731199.000708,"amplitude":0.073698,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.359454,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"listingDate":1638334800000,"exchange":"NASDAQ","adjPreClose":8.41,"postHourTrading":{"tag":"盘后","latestPrice":8.89,"preClose":8.89,"latestTime":"16:55 EST","volume":3100,"amount":27558,"timestamp":1770414923862,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.11172,"impliedVol":0.8981,"impliedVolPercentile":0.2948},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVCT\",,,,,undefined,":{"symbol":"NVCT","floatShares":14536600,"roa":"-62.40%","roe":"-145.00%","lyrEps":-1.110256,"volumeRatio":1.11172,"shares":25614896,"dividePrice":0,"high":8.965,"amplitude":0.073698,"preClose":8.41,"low":8.3452,"week52Low":5.55,"pbRate":"9.48","week52High":11.52,"institutionHeld":0,"latestPrice":8.89,"eps":-1.359454,"divideRate":0,"volume":82764,"delay":0,"ttmEps":-1.359454,"open":8.57,"prevYearClose":7.55,"prevWeekClose":8.11,"prevMonthClose":8.11,"prevQuarterClose":7.55},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVCT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-04","symbol":"NVCT","fiscalQuarterEnding":"2025/09","expectedEps":-0.24,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"pre","actualEps":-0.44},{"market":"US","date":"2025-08-05","symbol":"NVCT","fiscalQuarterEnding":"2025/06","expectedEps":-0.25,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"pre","actualEps":-0.3},{"market":"US","date":"2025-05-06","symbol":"NVCT","fiscalQuarterEnding":"2025/03","expectedEps":-0.3,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746504000000,"reportTimeType":"pre","actualEps":-0.27},{"market":"US","date":"2025-02-25","symbol":"NVCT","fiscalQuarterEnding":"2024/12","expectedEps":-0.28,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740459600000,"reportTimeType":"pre","actualEps":-0.36},{"market":"US","date":"2024-11-05","symbol":"NVCT","fiscalQuarterEnding":"2024/09","expectedEps":-0.26,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730782800000,"reportTimeType":"pre","actualEps":-0.24}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVCT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVCT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1667,"buy":0.8333,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8333,"analysts":6,"updateTime":1743570000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NVCT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NVCT","date":"2026-02-05","current":-6.53939,"percent":0.436214,"low":-4822.163542,"twenty":-11.108504,"median":-7.810226,"eighty":-6.142013,"high":-4.507629,"avg":-129.281235,"sd":656.330702,"marketCap":216702020},"quantilePoints":[{"date":"2022-02-04","current":-1722.20125,"twenty":-2416.901458,"median":-2416.901458,"eighty":-2000.081333,"marketCap":41332830},{"date":"2022-02-11","current":-3677.562083,"twenty":-3582.178633,"median":-3306.626438,"eighty":-2416.901458,"marketCap":88261490},{"date":"2022-02-18","current":-3105.261333,"twenty":-3521.769108,"median":-3195.345708,"eighty":-2596.861958,"marketCap":74526272},{"date":"2022-02-25","current":-3359.617208,"twenty":-3425.325841,"median":-3227.140208,"eighty":-2883.759766,"marketCap":80630813},{"date":"2022-03-04","current":-3990.207833,"twenty":-3634.109608,"median":-3354.318146,"eighty":-2982.322667,"marketCap":95764988},{"date":"2022-03-11","current":-4382.339833,"twenty":-4096.189467,"median":-3439.103458,"eighty":-3123.278208,"marketCap":105176156},{"date":"2022-03-18","current":-4149.180292,"twenty":-4143.881209,"median":-3592.776792,"eighty":-3195.345708,"marketCap":99580327},{"date":"2022-03-25","current":-7.409669,"twenty":-4111.026892,"median":-3439.103458,"eighty":-2883.759766,"marketCap":95510632},{"date":"2022-04-01","current":-6.926215,"twenty":-4060.1557,"median":-3354.318146,"eighty":-350.415344,"marketCap":89278913},{"date":"2022-04-08","current":-9.323751,"twenty":-4037.899584,"median":-3227.140208,"eighty":-8.266073,"marketCap":120183153},{"date":"2022-04-14","current":-9.965067,"twenty":-4016.70325,"median":-3195.345708,"eighty":-8.337111,"marketCap":128449719},{"date":"2022-04-22","current":-9.550678,"twenty":-3990.207833,"median":-3028.424667,"eighty":-9.234954,"marketCap":123108245},{"date":"2022-04-29","current":-9.373083,"twenty":-3905.422542,"median":-2416.901458,"eighty":-9.234954,"marketCap":120819043},{"date":"2022-05-06","current":-17.956854,"twenty":-3677.562083,"median":-870.079052,"eighty":-9.234954,"marketCap":231463850},{"date":"2022-05-13","current":-15.163214,"twenty":-3640.4685,"median":-14.858803,"eighty":-9.323751,"marketCap":239730416},{"date":"2022-05-20","current":-12.468425,"twenty":-3608.674042,"median":-15.011008,"eighty":-9.373083,"marketCap":197125807},{"date":"2022-05-27","current":-12.597132,"twenty":-3576.879542,"median":-14.366844,"eighty":-9.373083,"marketCap":199160654},{"date":"2022-06-03","current":-9.773637,"twenty":-3517.529842,"median":-13.793232,"eighty":-9.396762,"marketCap":154521197},{"date":"2022-06-10","current":-9.652975,"twenty":-3451.82125,"median":-12.774103,"eighty":-9.410576,"marketCap":152613528},{"date":"2022-06-17","current":-8.824428,"twenty":-3383.992992,"median":-12.70975,"eighty":-9.363217,"marketCap":139514200},{"date":"2022-06-24","current":-9.242723,"twenty":-3363.856475,"median":-12.468425,"eighty":-9.239615,"marketCap":146127453},{"date":"2022-07-01","current":-9.64493,"twenty":-3353.258333,"median":-11.474627,"eighty":-9.239615,"marketCap":152486350},{"date":"2022-07-08","current":-10.224109,"twenty":-3315.104967,"median":-10.465433,"eighty":-9.275134,"marketCap":161643161},{"date":"2022-07-15","current":-9.086265,"twenty":-3249.396358,"median":-10.409124,"eighty":-9.258683,"marketCap":143653842},{"date":"2022-07-22","current":-9.586449,"twenty":-3214.422408,"median":-10.216065,"eighty":-9.238062,"marketCap":151561766},{"date":"2022-07-29","current":-7.078848,"twenty":-3195.345708,"median":-9.9848,"eighty":-9.113213,"marketCap":111916587},{"date":"2022-08-05","current":-8.052111,"twenty":-3195.345708,"median":-9.910387,"eighty":-8.975658,"marketCap":108228426},{"date":"2022-08-12","current":-9.488582,"twenty":-3159.311958,"median":-9.805813,"eighty":-8.932791,"marketCap":127536026},{"date":"2022-08-19","current":-9.793611,"twenty":-3043.792,"median":-9.810606,"eighty":-8.975658,"marketCap":131635922},{"date":"2022-08-26","current":-9.510369,"twenty":-2917.673883,"median":-9.781681,"eighty":-9.015878,"marketCap":127828876},{"date":"2022-09-02","current":-9.031038,"twenty":-2686.842208,"median":-9.757814,"eighty":-8.975658,"marketCap":121386184},{"date":"2022-09-09","current":-9.150871,"twenty":-2416.901458,"median":-9.745482,"eighty":-8.964396,"marketCap":122996857},{"date":"2022-09-16","current":-8.932993,"twenty":-2277.961416,"median":-9.701239,"eighty":-8.937021,"marketCap":120068360},{"date":"2022-09-23","current":-8.573495,"twenty":-1381.352371,"median":-9.632337,"eighty":-8.826532,"marketCap":115236341},{"date":"2022-09-30","current":-7.723771,"twenty":-17.65393,"median":-9.586518,"eighty":-8.651931,"marketCap":103815204},{"date":"2022-10-07","current":-7.63662,"twenty":-16.210562,"median":-9.563205,"eighty":-8.405729,"marketCap":102643805},{"date":"2022-10-14","current":-7.603938,"twenty":-15.261352,"median":-9.524268,"eighty":-8.26218,"marketCap":102204531},{"date":"2022-10-21","current":-7.680195,"twenty":-15.169649,"median":-9.483135,"eighty":-8.073594,"marketCap":103229505},{"date":"2022-10-28","current":-7.810268,"twenty":-15.102332,"median":-9.471747,"eighty":-7.885,"marketCap":104977817},{"date":"2022-11-04","current":-7.576703,"twenty":-14.768455,"median":-9.451943,"eighty":-7.747738,"marketCap":101838469},{"date":"2022-11-11","current":-6.796511,"twenty":-14.399021,"median":-9.402682,"eighty":-7.680195,"marketCap":99568884},{"date":"2022-11-18","current":-7.224291,"twenty":-14.29948,"median":-9.348417,"eighty":-7.640977,"marketCap":105835867},{"date":"2022-11-25","current":-7.26627,"twenty":-14.030026,"median":-9.293004,"eighty":-7.625726,"marketCap":106450851},{"date":"2022-12-02","current":-7.506147,"twenty":-13.793232,"median":-9.25981,"eighty":-7.576703,"marketCap":109965047},{"date":"2022-12-09","current":-7.506147,"twenty":-12.999339,"median":-9.210288,"eighty":-7.516141,"marketCap":109965047},{"date":"2022-12-16","current":-7.406198,"twenty":-12.782147,"median":-9.150762,"eighty":-7.496152,"marketCap":108500799},{"date":"2022-12-23","current":-7.738527,"twenty":-12.766059,"median":-9.1187,"eighty":-7.454973,"marketCap":113369424},{"date":"2022-12-30","current":-7.496152,"twenty":-12.766059,"median":-9.099176,"eighty":-7.44634,"marketCap":109818622},{"date":"2023-01-06","current":-7.594801,"twenty":-12.732274,"median":-9.091333,"eighty":-7.450405,"marketCap":111263835},{"date":"2023-01-13","current":-7.406198,"twenty":-12.642179,"median":-9.041932,"eighty":-7.450257,"marketCap":108500799},{"date":"2023-01-20","current":-7.496152,"twenty":-12.545649,"median":-9.025531,"eighty":-7.451274,"marketCap":109818622},{"date":"2023-01-27","current":-7.975905,"twenty":-12.317195,"median":-8.981288,"eighty":-7.451274,"marketCap":116847014},{"date":"2023-02-03","current":-10.369677,"twenty":-11.855901,"median":-9.025531,"eighty":-7.452843,"marketCap":151915761},{"date":"2023-02-10","current":-14.362627,"twenty":-11.979785,"median":-9.058273,"eighty":-7.455453,"marketCap":210412480},{"date":"2023-02-17","current":-9.964884,"twenty":-11.831926,"median":-9.096402,"eighty":-7.46125,"marketCap":145985555},{"date":"2023-02-24","current":-10.434643,"twenty":-11.751993,"median":-9.101951,"eighty":-7.472325,"marketCap":152867522},{"date":"2023-03-03","current":-11.973853,"twenty":-11.789947,"median":-9.134127,"eighty":-7.486157,"marketCap":175416946},{"date":"2023-03-10","current":-8.326972,"twenty":-11.789947,"median":-9.107295,"eighty":-7.488136,"marketCap":158920261},{"date":"2023-03-17","current":-9.237161,"twenty":-11.658015,"median":-9.099176,"eighty":-7.496072,"marketCap":176291215},{"date":"2023-03-24","current":-9.086429,"twenty":-11.512116,"median":-9.107295,"eighty":-7.496152,"marketCap":173414497},{"date":"2023-03-31","current":-10.133823,"twenty":-11.492386,"median":-9.134127,"eighty":-7.496152,"marketCap":193404003},{"date":"2023-04-06","current":-9.75506,"twenty":-11.456868,"median":-9.150762,"eighty":-7.496152,"marketCap":186175325},{"date":"2023-04-14","current":-11.478815,"twenty":-11.451785,"median":-9.210288,"eighty":-7.496152,"marketCap":219073184},{"date":"2023-04-21","current":-10.705831,"twenty":-11.440849,"median":-9.236058,"eighty":-7.496152,"marketCap":204320781},{"date":"2023-04-28","current":-11.463355,"twenty":-11.463355,"median":-9.251266,"eighty":-7.496152,"marketCap":218778136},{"date":"2023-05-01","current":-12.211645,"twenty":-11.469477,"median":-9.25981,"eighty":-7.496152,"marketCap":233059240},{"date":"2023-05-12","current":-11.89369,"twenty":-11.658015,"median":-9.26808,"eighty":-7.496152,"marketCap":240145501},{"date":"2023-05-19","current":-13.141553,"twenty":-11.893853,"median":-9.303385,"eighty":-7.4981,"marketCap":265341095},{"date":"2023-05-26","current":-13.572736,"twenty":-12.376667,"median":-9.373083,"eighty":-7.505944,"marketCap":274047116},{"date":"2023-06-02","current":-13.905712,"twenty":-12.463106,"median":-9.391925,"eighty":-7.506147,"marketCap":280770234},{"date":"2023-06-09","current":-13.897784,"twenty":-12.70975,"median":-9.412549,"eighty":-7.506147,"marketCap":280610160},{"date":"2023-06-16","current":-14.42896,"twenty":-12.999339,"median":-9.452014,"eighty":-7.506147,"marketCap":291335135},{"date":"2023-06-23","current":-14.056344,"twenty":-13.239822,"median":-9.471747,"eighty":-7.514142,"marketCap":283811645},{"date":"2023-06-30","current":-12.954352,"twenty":-13.244502,"median":-9.481102,"eighty":-7.534132,"marketCap":261561324},{"date":"2023-07-07","current":-12.034704,"twenty":-13.213305,"median":-9.499475,"eighty":-7.55812,"marketCap":242992711},{"date":"2023-07-14","current":-12.082272,"twenty":-13.164951,"median":-9.548401,"eighty":-7.576348,"marketCap":243953157},{"date":"2023-07-21","current":-11.321184,"twenty":-13.104727,"median":-9.564908,"eighty":-7.580464,"marketCap":228586029},{"date":"2023-07-28","current":-11.154696,"twenty":-13.046317,"median":-9.586518,"eighty":-7.586105,"marketCap":225224469},{"date":"2023-08-04","current":-11.4956,"twenty":-13.024672,"median":-9.61481,"eighty":-7.589583,"marketCap":232107662},{"date":"2023-08-11","current":-11.568146,"twenty":-12.981344,"median":-9.64493,"eighty":-7.595321,"marketCap":258316695},{"date":"2023-08-18","current":-11.190253,"twenty":-12.938496,"median":-9.709283,"eighty":-7.5961,"marketCap":249878349},{"date":"2023-08-25","current":-11.167117,"twenty":-12.914712,"median":-9.749504,"eighty":-7.599235,"marketCap":249361716},{"date":"2023-09-01","current":-11.036011,"twenty":-12.870315,"median":-9.760327,"eighty":-7.612653,"marketCap":246434127},{"date":"2023-09-08","current":-11.151692,"twenty":-12.799405,"median":-9.777659,"eighty":-7.625726,"marketCap":249017293},{"date":"2023-09-15","current":-10.81236,"twenty":-12.778929,"median":-9.805813,"eighty":-7.625726,"marketCap":241440004},{"date":"2023-09-22","current":-10.550149,"twenty":-12.766059,"median":-9.8581,"eighty":-7.627797,"marketCap":235584825},{"date":"2023-09-29","current":-10.642694,"twenty":-12.754797,"median":-9.91491,"eighty":-7.636188,"marketCap":237651359},{"date":"2023-10-06","current":-8.38305,"twenty":-12.687226,"median":-9.900583,"eighty":-7.63662,"marketCap":187193498},{"date":"2023-10-13","current":-7.380477,"twenty":-12.582954,"median":-9.815398,"eighty":-7.63662,"marketCap":164806051},{"date":"2023-10-20","current":-6.994872,"twenty":-12.517778,"median":-9.787646,"eighty":-7.625726,"marketCap":156195494},{"date":"2023-10-27","current":-6.856054,"twenty":-12.500855,"median":-9.777659,"eighty":-7.617011,"marketCap":153095694},{"date":"2023-11-03","current":-7.295644,"twenty":-12.474627,"median":-9.75506,"eighty":-7.591323,"marketCap":162911728},{"date":"2023-11-10","current":-6.384789,"twenty":-12.465234,"median":-9.745482,"eighty":-7.564117,"marketCap":142597868},{"date":"2023-11-17","current":-6.361515,"twenty":-12.460749,"median":-9.701239,"eighty":-7.506147,"marketCap":142078070},{"date":"2023-11-24","current":-6.361515,"twenty":-12.450927,"median":-9.64493,"eighty":-7.496152,"marketCap":142078070},{"date":"2023-12-01","current":-6.594253,"twenty":-12.430299,"median":-9.61481,"eighty":-7.496152,"marketCap":147276049},{"date":"2023-12-08","current":-6.547705,"twenty":-12.335412,"median":-9.586518,"eighty":-7.486157,"marketCap":146236453},{"date":"2023-12-15","current":-6.625285,"twenty":-12.194779,"median":-9.564908,"eighty":-7.452843,"marketCap":147969112},{"date":"2023-12-22","current":-6.260661,"twenty":-12.140939,"median":-9.548401,"eighty":-7.432254,"marketCap":139825613},{"date":"2023-12-29","current":-6.648559,"twenty":-12.098128,"median":-9.517319,"eighty":-7.416193,"marketCap":148488910},{"date":"2024-01-05","current":-6.4934,"twenty":-12.093462,"median":-9.488582,"eighty":-7.408281,"marketCap":145023591},{"date":"2024-01-12","current":-7.54848,"twenty":-12.085504,"median":-9.474718,"eighty":-7.408281,"marketCap":168587759},{"date":"2024-01-19","current":-6.439094,"twenty":-12.082272,"median":-9.46188,"eighty":-7.391646,"marketCap":143810730},{"date":"2024-01-26","current":-5.996891,"twenty":-12.063245,"median":-9.451871,"eighty":-7.358883,"marketCap":133934571},{"date":"2024-02-02","current":-5.539173,"twenty":-12.010364,"median":-9.403927,"eighty":-7.324002,"marketCap":123711881},{"date":"2024-02-09","current":-5.345224,"twenty":-11.96331,"median":-9.373083,"eighty":-7.303747,"marketCap":119380232},{"date":"2024-02-16","current":-6.105503,"twenty":-11.93164,"median":-9.313568,"eighty":-7.27802,"marketCap":136360294},{"date":"2024-02-23","current":-5.787427,"twenty":-11.905064,"median":-9.279216,"eighty":-7.226222,"marketCap":129256391},{"date":"2024-03-01","current":-7.657092,"twenty":-11.893853,"median":-9.25981,"eighty":-7.201903,"marketCap":171013482},{"date":"2024-03-08","current":-8.110119,"twenty":-11.888595,"median":-9.239942,"eighty":-7.226222,"marketCap":180531251},{"date":"2024-03-15","current":-7.303897,"twenty":-11.863459,"median":-9.185622,"eighty":-7.234415,"marketCap":162584739},{"date":"2024-03-22","current":-7.224073,"twenty":-11.84433,"median":-9.144455,"eighty":-7.224117,"marketCap":160807857},{"date":"2024-03-28","current":-6.657322,"twenty":-11.84392,"median":-9.1187,"eighty":-7.196306,"marketCap":148191992},{"date":"2024-04-05","current":-6.154431,"twenty":-11.813935,"median":-9.096402,"eighty":-7.141402,"marketCap":136997633},{"date":"2024-04-12","current":-5.922941,"twenty":-11.807221,"median":-9.086347,"eighty":-7.106352,"marketCap":131844674},{"date":"2024-04-19","current":-5.364173,"twenty":-11.73344,"median":-9.082564,"eighty":-7.087417,"marketCap":119406497},{"date":"2024-04-26","current":-5.196543,"twenty":-11.725512,"median":-9.036485,"eighty":-7.056377,"marketCap":115675044},{"date":"2024-05-03","current":-5.5789,"twenty":-11.693997,"median":-9.020144,"eighty":-6.994872,"marketCap":124186324},{"date":"2024-05-10","current":-5.232404,"twenty":-11.670016,"median":-8.943064,"eighty":-6.926009,"marketCap":117111662},{"date":"2024-05-17","current":-5.355423,"twenty":-11.568146,"median":-8.86763,"eighty":-6.867017,"marketCap":119865071},{"date":"2024-05-24","current":-5.478442,"twenty":-11.551096,"median":-8.824241,"eighty":-6.807818,"marketCap":122618480},{"date":"2024-05-31","current":-5.248806,"twenty":-11.540057,"median":-8.78056,"eighty":-6.750346,"marketCap":117478784},{"date":"2024-06-07","current":-5.355423,"twenty":-11.535651,"median":-8.71467,"eighty":-6.643904,"marketCap":119865071},{"date":"2024-06-14","current":-5.601461,"twenty":-11.522593,"median":-8.700328,"eighty":-6.585481,"marketCap":125371889},{"date":"2024-06-21","current":-5.601461,"twenty":-11.514132,"median":-8.595282,"eighty":-6.550808,"marketCap":125371889},{"date":"2024-06-28","current":-5.14219,"twenty":-11.514103,"median":-8.591276,"eighty":-6.544445,"marketCap":115092496},{"date":"2024-07-05","current":-5.084781,"twenty":-11.509505,"median":-8.549205,"eighty":-6.524432,"marketCap":113807572},{"date":"2024-07-12","current":-5.248806,"twenty":-11.505115,"median":-8.477607,"eighty":-6.501158,"marketCap":117478784},{"date":"2024-07-15","current":-5.396429,"twenty":-11.504671,"median":-8.471907,"eighty":-6.499606,"marketCap":120782874},{"date":"2024-08-02","current":-5.068379,"twenty":-11.504226,"median":-8.439046,"eighty":-6.4934,"marketCap":113440450},{"date":"2024-08-09","current":-6.04608,"twenty":-11.4956,"median":-8.380128,"eighty":-6.446852,"marketCap":127584385},{"date":"2024-08-16","current":-5.568758,"twenty":-11.4956,"median":-8.33936,"eighty":-6.431336,"marketCap":117511934},{"date":"2024-08-23","current":-6.364295,"twenty":-11.487672,"median":-8.317646,"eighty":-6.400304,"marketCap":134299353},{"date":"2024-08-30","current":-6.001884,"twenty":-11.478815,"median":-8.282792,"eighty":-6.361515,"marketCap":126651751},{"date":"2024-09-06","current":-5.445008,"twenty":-11.472569,"median":-8.234715,"eighty":-6.361515,"marketCap":114900558},{"date":"2024-09-13","current":-5.745544,"twenty":-11.464886,"median":-8.172852,"eighty":-6.350611,"marketCap":121242472},{"date":"2024-09-20","current":-5.966527,"twenty":-11.457439,"median":-8.106128,"eighty":-6.299451,"marketCap":125905644},{"date":"2024-09-27","current":-5.445008,"twenty":-11.447214,"median":-8.0288,"eighty":-6.249174,"marketCap":114900558},{"date":"2024-10-04","current":-5.445008,"twenty":-11.428314,"median":-7.993998,"eighty":-6.196292,"marketCap":114900558},{"date":"2024-10-11","current":-5.471526,"twenty":-11.41595,"median":-7.975905,"eighty":-6.137667,"marketCap":115460138},{"date":"2024-10-18","current":-5.975366,"twenty":-11.389225,"median":-7.92057,"eighty":-6.076134,"marketCap":126092170},{"date":"2024-10-25","current":-7.734386,"twenty":-11.342169,"median":-7.870838,"eighty":-6.088277,"marketCap":163211020},{"date":"2024-10-31","current":-6.974207,"twenty":-11.32549,"median":-7.854682,"eighty":-6.099297,"marketCap":147169708},{"date":"2024-11-08","current":-8.029494,"twenty":-11.299815,"median":-7.828418,"eighty":-6.086567,"marketCap":155563417},{"date":"2024-11-15","current":-5.516667,"twenty":-11.283906,"median":-7.854682,"eighty":-6.086567,"marketCap":106879902},{"date":"2024-11-22","current":-4.886589,"twenty":-11.259662,"median":-7.803133,"eighty":-6.007187,"marketCap":94672767},{"date":"2024-11-29","current":-5.026205,"twenty":-11.229851,"median":-7.772793,"eighty":-5.982437,"marketCap":97377703},{"date":"2024-12-06","current":-4.746972,"twenty":-11.207233,"median":-7.743226,"eighty":-5.930799,"marketCap":91967831},{"date":"2024-12-13","current":-4.6273,"twenty":-11.199507,"median":-7.732114,"eighty":-5.891293,"marketCap":89649314},{"date":"2024-12-20","current":-4.677163,"twenty":-11.187168,"median":-7.695034,"eighty":-5.858687,"marketCap":90615363},{"date":"2024-12-27","current":-5.00626,"twenty":-11.179456,"median":-7.680195,"eighty":-5.833974,"marketCap":96991284},{"date":"2025-01-03","current":-5.375247,"twenty":-11.167117,"median":-7.680195,"eighty":-5.765486,"marketCap":104140044},{"date":"2025-01-10","current":-6.153113,"twenty":-11.15718,"median":-7.674115,"eighty":-5.765219,"marketCap":119210403},{"date":"2025-01-17","current":-5.445056,"twenty":-11.152293,"median":-7.657092,"eighty":-5.745544,"marketCap":105492512},{"date":"2025-01-24","current":-6.402428,"twenty":-11.143981,"median":-7.63662,"eighty":-5.743678,"marketCap":124040646},{"date":"2025-01-31","current":-6.721552,"twenty":-11.137297,"median":-7.62606,"eighty":-5.745544,"marketCap":130223358},{"date":"2025-02-07","current":-8.933023,"twenty":-11.094623,"median":-7.625726,"eighty":-5.756709,"marketCap":173068391},{"date":"2025-02-14","current":-8.575209,"twenty":-11.04835,"median":-7.63608,"eighty":-5.764953,"marketCap":166136094},{"date":"2025-02-21","current":-9.278499,"twenty":-11.027345,"median":-7.63662,"eighty":-5.774262,"marketCap":179761644},{"date":"2025-02-28","current":-8.442054,"twenty":-11.010673,"median":-7.657749,"eighty":-5.790095,"marketCap":160399020},{"date":"2025-03-07","current":-7.571459,"twenty":-11.00084,"median":-7.658407,"eighty":-5.794098,"marketCap":143857718},{"date":"2025-03-14","current":-10.279948,"twenty":-10.991897,"median":-7.680195,"eighty":-5.810034,"marketCap":195319016},{"date":"2025-03-21","current":-11.51108,"twenty":-11.024301,"median":-7.680195,"eighty":-5.833952,"marketCap":218710515},{"date":"2025-03-28","current":-11.880419,"twenty":-11.05452,"median":-7.709402,"eighty":-5.833974,"marketCap":225727965},{"date":"2025-04-04","current":-11.14174,"twenty":-11.147711,"median":-7.734386,"eighty":-5.837495,"marketCap":211693065},{"date":"2025-04-11","current":-10.495396,"twenty":-11.14058,"median":-7.744393,"eighty":-5.846312,"marketCap":199412528},{"date":"2025-04-17","current":-10.710844,"twenty":-11.149702,"median":-7.758662,"eighty":-5.855152,"marketCap":203506041},{"date":"2025-04-25","current":-13.493202,"twenty":-11.164633,"median":-7.795998,"eighty":-5.871062,"marketCap":256370829},{"date":"2025-05-02","current":-11.843485,"twenty":-11.207752,"median":-7.810247,"eighty":-5.879113,"marketCap":225026220},{"date":"2025-05-09","current":-10.697367,"twenty":-11.237045,"median":-7.846568,"eighty":-5.884079,"marketCap":215669620},{"date":"2025-05-16","current":-10.878873,"twenty":-11.207752,"median":-7.868697,"eighty":-5.889786,"marketCap":219328958},{"date":"2025-05-23","current":-11.664309,"twenty":-11.314061,"median":-7.913104,"eighty":-5.895991,"marketCap":235164130},{"date":"2025-05-30","current":-10.960933,"twenty":-11.324344,"median":-7.941649,"eighty":-5.896706,"marketCap":220983379},{"date":"2025-06-06","current":-10.515462,"twenty":-11.324344,"median":-7.987178,"eighty":-5.92233,"marketCap":212002236},{"date":"2025-06-13","current":-10.351341,"twenty":-11.321184,"median":-8.017247,"eighty":-5.922941,"marketCap":208693394},{"date":"2025-06-20","current":-9.436953,"twenty":-11.292692,"median":-8.029494,"eighty":-5.938657,"marketCap":190258417},{"date":"2025-06-27","current":-9.038374,"twenty":-11.283352,"median":-8.106128,"eighty":-5.948792,"marketCap":182222658},{"date":"2025-07-03","current":-8.839084,"twenty":-11.259662,"median":-8.16619,"eighty":-5.960054,"marketCap":178204778},{"date":"2025-07-11","current":-12.134732,"twenty":-11.299815,"median":-8.221117,"eighty":-5.97183,"marketCap":244648338},{"date":"2025-07-18","current":-11.779136,"twenty":-11.352391,"median":-8.261696,"eighty":-5.985973,"marketCap":237479156},{"date":"2025-07-25","current":-11.453172,"twenty":-11.417996,"median":-8.290504,"eighty":-5.995352,"marketCap":230907406},{"date":"2025-08-01","current":-10.3123,"twenty":-11.417996,"median":-8.322309,"eighty":-5.999887,"marketCap":207906280},{"date":"2025-08-08","current":-7.117812,"twenty":-11.413115,"median":-8.317646,"eighty":-6.007187,"marketCap":157068752},{"date":"2025-08-15","current":-7.417752,"twenty":-11.397816,"median":-8.284795,"eighty":-6.031937,"marketCap":163687532},{"date":"2025-08-22","current":-7.313926,"twenty":-11.38502,"median":-8.248313,"eighty":-6.051384,"marketCap":161396416},{"date":"2025-08-29","current":-7.533114,"twenty":-11.352391,"median":-8.20553,"eighty":-6.07083,"marketCap":166233217},{"date":"2025-09-05","current":-7.521577,"twenty":-11.328906,"median":-8.16619,"eighty":-6.082184,"marketCap":165978648},{"date":"2025-09-12","current":-7.510041,"twenty":-11.324344,"median":-8.102137,"eighty":-6.085977,"marketCap":165724080},{"date":"2025-09-19","current":-7.383143,"twenty":-11.32308,"median":-8.029147,"eighty":-6.096193,"marketCap":162923827},{"date":"2025-09-26","current":-6.864016,"twenty":-11.306938,"median":-7.99534,"eighty":-6.117091,"marketCap":151468245},{"date":"2025-10-03","current":-7.00245,"twenty":-11.284461,"median":-7.978803,"eighty":-6.13607,"marketCap":154523067},{"date":"2025-10-10","current":-6.933233,"twenty":-11.273902,"median":-7.941649,"eighty":-6.14394,"marketCap":152995656},{"date":"2025-10-17","current":-7.025522,"twenty":-11.254029,"median":-7.919223,"eighty":-6.152536,"marketCap":155032204},{"date":"2025-10-24","current":-6.933233,"twenty":-11.238912,"median":-7.886612,"eighty":-6.15364,"marketCap":152995656},{"date":"2025-10-31","current":-7.660011,"twenty":-11.221863,"median":-7.867109,"eighty":-6.157055,"marketCap":169033470},{"date":"2025-11-07","current":-5.723379,"twenty":-11.207233,"median":-7.846568,"eighty":-6.152536,"marketCap":145236460},{"date":"2025-11-14","current":-5.975732,"twenty":-11.203923,"median":-7.810247,"eighty":-6.130076,"marketCap":151640184},{"date":"2025-11-21","current":-5.935356,"twenty":-11.196876,"median":-7.805374,"eighty":-6.106084,"marketCap":150615588},{"date":"2025-11-28","current":-6.298745,"twenty":-11.189497,"median":-7.789134,"eighty":-6.105794,"marketCap":159836951},{"date":"2025-12-05","current":-6.808499,"twenty":-11.185688,"median":-7.751005,"eighty":-6.09309,"marketCap":172772473},{"date":"2025-12-12","current":-7.65136,"twenty":-11.180364,"median":-7.740764,"eighty":-6.105794,"marketCap":194160911},{"date":"2025-12-19","current":-8.055126,"twenty":-11.17075,"median":-7.739645,"eighty":-6.108975,"marketCap":204406870},{"date":"2025-12-26","current":-7.782584,"twenty":-11.167117,"median":-7.744393,"eighty":-6.11705,"marketCap":197490848},{"date":"2026-01-02","current":-7.621078,"twenty":-11.15718,"median":-7.744393,"eighty":-6.125125,"marketCap":193392464},{"date":"2026-01-09","current":-8.933316,"twenty":-11.152293,"median":-7.756452,"eighty":-6.133007,"marketCap":226691829},{"date":"2026-01-16","current":-8.610304,"twenty":-11.14373,"median":-7.77249,"eighty":-6.136686,"marketCap":218495062},{"date":"2026-01-23","current":-8.842469,"twenty":-11.14,"median":-7.785859,"eighty":-6.137239,"marketCap":224386488},{"date":"2026-01-30","current":-8.600209,"twenty":-11.137297,"median":-7.805374,"eighty":-6.137975,"marketCap":218238913},{"date":"2026-02-05","current":-8.539645,"twenty":-11.108504,"median":-7.810226,"eighty":-6.142013,"marketCap":216702020}],"updateTime":1770444169107},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVCT\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2592994042","title":"Nuvectis Pharma Announces the Initiation of the Phase 1B Study of Nxp900 in Combination With Osimertinib in Patients With Nsclc","url":"https://stock-news.laohu8.com/highlight/detail?id=2592994042","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592994042?lang=en_us&edition=fundamental","pubTime":"2025-12-17 20:00","pubTimestamp":1765972803,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nTUADYJSQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NVCT","BK4139"],"gpt_icon":0},{"id":"2592992590","title":"Nuvectis Pharma Announces the Initiation of the Phase 1b Study of NXP900 in Combination with Osimertinib in Patients with NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2592992590","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592992590?lang=en_us&edition=fundamental","pubTime":"2025-12-17 20:00","pubTimestamp":1765972800,"startTime":"0","endTime":"0","summary":"The study is designed to evaluate the safety and clinical activity of NXP900 in combination with osimertinib in patients with epidermal growth factor receptor mutated (EGFR mut+) non-small cell lung c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/17/3206848/0/en/Nuvectis-Pharma-Announces-the-Initiation-of-the-Phase-1b-Study-of-NXP900-in-Combination-with-Osimertinib-in-Patients-with-NSCLC.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVCT","BK4139"],"gpt_icon":0},{"id":"2586912473","title":"Nuvectis Pharma Hosts Virtual Meeting on NXP900 Phase 1b Program in Advanced Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2586912473","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586912473?lang=en_us&edition=fundamental","pubTime":"2025-11-25 21:00","pubTimestamp":1764075624,"startTime":"0","endTime":"0","summary":"Nuvectis Pharma Inc. will host a virtual Key Opinion Leader Meeting on Tuesday, December 2, 2025, at 8:00 AM ET to discuss the NXP900 Phase 1b Program in advanced solid tumors, including its combination with osimertinib in non-small cell lung cancer. The event will feature experts including Dr. Alexander Spira and Dr. Asier Uncita-Broceta, and will cover key preclinical and clinical data and development strategies for NXP900. A live Q&A session will follow, and a replay will be available on the company's website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuvectis Pharma Inc. published the original content used to generate this news brief via GlobeNewswire  on November 25, 2025, and is solely responsible for the information contain","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nNDLbF7M1Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","BK4112","IE00BGHQF748.EUR","IE00B64PRP62.GBP","NVCT","NDAQ","LU2210149790.SGD","LU2210150020.SGD","BK4139","LU2095319765.USD","IE00B3QW5Z07.USD","BK4585","BK4588","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2584541889","title":"Buy Rating for Nuvectis Pharma’s NXP900 Driven by Promising Efficacy and Development Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2584541889","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584541889?lang=en_us&edition=fundamental","pubTime":"2025-11-19 00:55","pubTimestamp":1763484925,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Naz Rahman from Maxim Group maintained a Buy rating on Nuvectis Pharma, with a price target of $17.00. Naz Rahman h...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-for-nuvectis-pharmas-nxp900-driven-by-promising-efficacy-and-development-progress-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-for-nuvectis-pharmas-nxp900-driven-by-promising-efficacy-and-development-progress-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVCT","PRGS"],"gpt_icon":0},{"id":"2581026333","title":"Nuvectis Pharma Executives Make Bold Moves with Major Stock Purchases!","url":"https://stock-news.laohu8.com/highlight/detail?id=2581026333","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581026333?lang=en_us&edition=fundamental","pubTime":"2025-11-07 10:07","pubTimestamp":1762481264,"startTime":"0","endTime":"0","summary":"New insider activity at Nuvectis Pharma ( ($NVCT) ) has taken place on November 6, 2025. In a series of significant transactions, key figures at Nu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/nuvectis-pharma-executives-make-bold-moves-with-major-stock-purchases-insider-trading?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/nuvectis-pharma-executives-make-bold-moves-with-major-stock-purchases-insider-trading?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","NVCT"],"gpt_icon":0},{"id":"2581009353","title":"Director Matthew L. Kaplan Acquires Common Shares of Nuvectis Pharma Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2581009353","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581009353?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:01","pubTimestamp":1762434068,"startTime":"0","endTime":"0","summary":"Matthew L. Kaplan, Director of Nuvectis Pharma Inc., reported the acquisition of common shares of Nuvectis Pharma Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuvectis Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 06, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDL2BLPq4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Director Matthew L. Kaplan Acquires Common Shares of Nuvectis Pharma Inc","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NVCT"],"gpt_icon":0},{"id":"2581770198","title":"Maxim Group Reaffirms Their Buy Rating on Nuvectis Pharma (NVCT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2581770198","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581770198?lang=en_us&edition=fundamental","pubTime":"2025-11-06 01:36","pubTimestamp":1762364161,"startTime":"0","endTime":"0","summary":"Maxim Group analyst Naz Rahman reiterated a Buy rating on Nuvectis Pharma yesterday and set a price target of $17.00. According to TipRanks, Rahman...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/maxim-group-reaffirms-their-buy-rating-on-nuvectis-pharma-nvct-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/maxim-group-reaffirms-their-buy-rating-on-nuvectis-pharma-nvct-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVCT"],"gpt_icon":0},{"id":"2581279711","title":"Nuvectis Pharma Reports Progress in Oncology Drug Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2581279711","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581279711?lang=en_us&edition=fundamental","pubTime":"2025-11-05 13:05","pubTimestamp":1762319124,"startTime":"0","endTime":"0","summary":"Nuvectis Pharma, Inc. ( ($NVCT) ) has released its Q3 earnings. Here is a breakdown of the information Nuvectis Pharma, Inc. presented to its inves...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nuvectis-pharma-reports-progress-in-oncology-drug-development?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nuvectis-pharma-reports-progress-in-oncology-drug-development?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4097","LU2065732104.USD","BK4139","PRGS","NVCT"],"gpt_icon":0},{"id":"2580627756","title":"Analysts Offer Insights on Healthcare Companies: Alpha Teknova (TKNO) and Nuvectis Pharma (NVCT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2580627756","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580627756?lang=en_us&edition=fundamental","pubTime":"2025-11-04 23:31","pubTimestamp":1762270278,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alpha Teknova (TKNO – Research Report) and Nuvectis ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alpha-teknova-tkno-and-nuvectis-pharma-nvct-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alpha-teknova-tkno-and-nuvectis-pharma-nvct-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","BK4581","BK4139","BK4588","XBI","BK4539","BK4121","LABU","HCSG","XLV","LU0029874061.USD","TKNO","NVCT","BK4137","BK4585"],"gpt_icon":0},{"id":"2580873298","title":"Nuvectis Pharma Q3 EPS $(0.44) Misses $(0.25) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2580873298","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580873298?lang=en_us&edition=fundamental","pubTime":"2025-11-04 21:30","pubTimestamp":1762263038,"startTime":"0","endTime":"0","summary":"Nuvectis Pharma (NASDAQ:NVCT) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of $(0.25) by 73.91 percent. This is a 83.33 percent decrease over losses of $(0.24) per share from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48618467/nuvectis-pharma-q3-eps-0-44-misses-0-25-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVCT"],"gpt_icon":0},{"id":"2580734428","title":"BRIEF-Nuvectis Pharma Q3 EPS USD -0.44","url":"https://stock-news.laohu8.com/highlight/detail?id=2580734428","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580734428?lang=en_us&edition=fundamental","pubTime":"2025-11-04 21:15","pubTimestamp":1762262146,"startTime":"0","endTime":"0","summary":"BRIEF-Nuvectis Pharma Q3 EPS USD -0.44\n\n\nNov 04 (Reuters) - Nuvectis Pharma Q3 operating income USD -7.794 million.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nPLX4C862A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVCT","BK4139"],"gpt_icon":0},{"id":"2580739647","title":"Nuvectis Pharma Q3 net loss widens","url":"https://stock-news.laohu8.com/highlight/detail?id=2580739647","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580739647?lang=en_us&edition=fundamental","pubTime":"2025-11-04 20:37","pubTimestamp":1762259856,"startTime":"0","endTime":"0","summary":"Nuvectis Pharma Q3 net loss widensOverviewNuvectis Q3 net loss widens to $7.5 mln, driven by milestone and study costsCash position improves to $35.4 mln, supported by public offering and ATM facility","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nL1N3WG0LH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVCT","BK4139"],"gpt_icon":0},{"id":"2580973986","title":"Nuvectis Pharma Inc: Cash Runway Expected to Support Company's Operations Into 3Q-2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2580973986","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580973986?lang=en_us&edition=fundamental","pubTime":"2025-11-04 20:30","pubTimestamp":1762259456,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nFWN3WG0AN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NVCT"],"gpt_icon":0},{"id":"2580360017","title":"Nuvectis Pharma reports third quarter net loss of $7.5 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2580360017","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580360017?lang=en_us&edition=fundamental","pubTime":"2025-11-04 20:30","pubTimestamp":1762259427,"startTime":"0","endTime":"0","summary":"Nuvectis Pharma Inc. reported cash and cash equivalents of $35.4 million as of September 30, 2025, up from $18.5 million at the end of 2024, primarily due to a public offering in February 2025 and the use of its At-the-Market facility. The company reported a net loss of $7.5 million for the third quarter of 2025, compared to a net loss of $4.2 million for the same period in 2024. The increase in net loss was mainly attributed to a one-time $2.0 million milestone expense for NXP900, $0.7 million related to a clinical drug-drug interaction study, and $1.5 million in non-cash stock-based compensation. Key business developments included the initiation of the NXP900 Phase 1b program as a single agent, completion of the Phase 1a dose escalation study, and the successful completion of a clinical drug-drug interaction study in healthy volunteers. The company expects its cash runway to support operations into the third quarter of 2027.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nNDL5rpF2Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2210149790.SGD","NVCT","BK4585","LU2210150020.SGD","BK4139","IE00BKPKM429.USD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","LU0314104364.USD","NDAQ","BK4112","LU2095319765.USD","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2580736064","title":"Nuvectis Pharma Q3 Net Income USD -7.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2580736064","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580736064?lang=en_us&edition=fundamental","pubTime":"2025-11-04 20:30","pubTimestamp":1762259401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nPLX9E5DB1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NVCT","BK4139"],"gpt_icon":0},{"id":"2580739917","title":"Nuvectis Pharma, Inc. Reports Third Quarter 2025 Financial Results and Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2580739917","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580739917?lang=en_us&edition=fundamental","pubTime":"2025-11-04 20:30","pubTimestamp":1762259400,"startTime":"0","endTime":"0","summary":"NXP900 Phase 1b program initiated; single agent study underway, aiming to provide preliminary evidence of clinical efficacy in patients with molecularly and histologically defined advanced cancers; in","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/04/3180214/0/en/Nuvectis-Pharma-Inc-Reports-Third-Quarter-2025-Financial-Results-and-Business-Highlights.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVCT","BK4139"],"gpt_icon":0},{"id":"2579146933","title":"Nuvectis Pharma Inc. Files Initial Statement of Beneficial Ownership; Director Juan Sanchez Named as Beneficial Owner","url":"https://stock-news.laohu8.com/highlight/detail?id=2579146933","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579146933?lang=en_us&edition=fundamental","pubTime":"2025-10-31 20:00","pubTimestamp":1761912045,"startTime":"0","endTime":"0","summary":"Nuvectis Pharma Inc. has filed an initial statement of beneficial ownership with the U.S. Securities and Exchange Commission. The filing lists Juan Sanchez as the beneficial owner in his role as Director of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuvectis Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 31, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251031:nNDLBK4cw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVCT","BK4139"],"gpt_icon":0},{"id":"2579501991","title":"Major Investment Alert: Insider Buys Big in Nuvectis Pharma!","url":"https://stock-news.laohu8.com/highlight/detail?id=2579501991","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579501991?lang=en_us&edition=fundamental","pubTime":"2025-10-30 10:04","pubTimestamp":1761789868,"startTime":"0","endTime":"0","summary":"New insider activity at Nuvectis Pharma ( ($NVCT) ) has taken place on October 29, 2025. Significant shareholder Marlio Charles Mosseri has made a ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-investment-alert-insider-buys-big-in-nuvectis-pharma-insider-trading-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-investment-alert-insider-buys-big-in-nuvectis-pharma-insider-trading-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVCT","BK4139"],"gpt_icon":0},{"id":"2578969030","title":"Roth MKM Sticks to Its Buy Rating for Nuvectis Pharma (NVCT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2578969030","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578969030?lang=en_us&edition=fundamental","pubTime":"2025-10-28 23:15","pubTimestamp":1761664542,"startTime":"0","endTime":"0","summary":"Roth MKM analyst maintained a Buy rating on Nuvectis Pharma today and set a price target of $20.00. The company’s shares opened today at $6.61. Nuv...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/roth-mkm-sticks-to-its-buy-rating-for-nuvectis-pharma-nvct-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/roth-mkm-sticks-to-its-buy-rating-for-nuvectis-pharma-nvct-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVCT"],"gpt_icon":0},{"id":"2578994678","title":"Nuvectis Pharma’s Phase 1 Study of NXP900: A Potential Game-Changer in Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2578994678","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578994678?lang=en_us&edition=fundamental","pubTime":"2025-10-28 03:53","pubTimestamp":1761594822,"startTime":"0","endTime":"0","summary":"Nuvectis Pharma, Inc. (($NVCT)) announced an update on their ongoing clinical study. Nuvectis Pharma, Inc. is currently conducting a Phase 1 clinic...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nuvectis-pharmas-phase-1-study-of-nxp900-a-potential-game-changer-in-cancer-treatment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nuvectis-pharmas-phase-1-study-of-nxp900-a-potential-game-changer-in-cancer-treatment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVCT","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":39,"code":"91000000","status":"200"}]}}